Sensitization to oral enoxolone.
Villas Martínez
F
F
Sección de Alergología, Hospital de Amara, San Sebastián, Spain.
Joral Badas
A
A
Garmendia Goitia
J F
JF
Aguirre
I
I
D000284:Administration, Oral; D000799:Angioedema / Q000139:chemically induced*; D001566:Benzocaine / Q000009:adverse effects; D002710:Chlorhexidine; D004338:Drug Combinations; D003875:Drug Eruptions / Q000209:etiology*; D005148:Facial Dermatoses / Q000139:chemically induced*; D005260:Female; D006034:Glycyrrhetinic Acid / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D013280:Stomatitis / Q000139:chemically induced; D013414:Sulfaguanidine / Q000009:adverse effects; D013607:Tablets; D014449:Tyrothricin / Q000009:adverse effects
D004338:Drug Combinations; D013607:Tablets; C087326:benzocaine, chlorhexidine, enoxolone drug combination; D014449:Tyrothricin; D013414:Sulfaguanidine; D006034:Glycyrrhetinic Acid; D002710:Chlorhexidine; D001566:Benzocaine